Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.92 USD | +3.94% | +4.49% | -6.28% |
02/04 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
02/04 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.28% | 414M | |
+2.56% | 42.75B | |
+47.70% | 41.61B | |
+12.12% | 41.34B | |
-8.83% | 26.59B | |
+8.21% | 25.49B | |
-22.68% | 18.12B | |
+30.86% | 12.24B | |
-1.63% | 11.76B | |
+9.16% | 11B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Wedbush Adjusts Voyager Therapeutics Price Target to $4 From $3, Maintains Neutral Rating